The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 8.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (16 analysts) rates it buy, with a mean price target of $18.
StoneCo Ltd.
STNE · Nasdaq · USD · Market cap $2.2B
StoneCo Ltd.
FAIL · Does not pass the screenAt the last full screen
2026-09-15
Screened 2026-09-15 · the tape above runs as of 05:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
StoneCo Ltd. holds its Accumulation at $9.67. The statistical read favours the buyers, held for 40 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 40 days |
| Price at the screen | $9.67 |
| Valuation | 3.62 trailing · 4.22 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.62 |
Five Screens, Shown in Full
Does not pass. Accounts receivable
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 28.22% | Below 33% | Interest-bearing debt is just 28.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 4.78% | Below 33% | Cash held in interest-bearing accounts and securities is 4.8% of assets, under the one-third limit. | Pass |
| Receivables | 74.35% | Below 49% | Money owed to the company is 74.4% of assets, above the 49% limit. | Fail |
| Revenue purity | 5.63% | Below 5% | 5.6% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-15 screen. The gold marker is the market price at the same screen. A 79.2% margin of safety to the base estimate.
Third-party analyst targets: 17 covering, consensus Buy. The average target sits +43% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-15 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBrazil merchants still shuffle cash through old pipes
StoneCo wires payments and digital banking into the daily grind of Brazilian merchants, from corner shops to online sellers. It clears transactions and offers prepayments where global card networks still stumble. The numbers look tidy on paper, with a 26% profit margin, 31% return on equity and a forward multiple of just 4.7 times, yet revenue is crawling along at only 4% a year.
We pass because the business shows no clear edge. An unknown moat and single-digit growth leave it exposed even at this depressed price. Analyst targets sit around 17 dollars against our own higher fair value, but the low growth and patchy competitive position outweigh any apparent bargain.
Brazil currency swings and regulatory shifts sit at the heart of the risk. A sudden policy change or economic slowdown can wipe out thin margins fast, and the unknown moat offers little defence. Analysis, not advice.
| Forward P/E | 4.2xexpensive even after accounting for its growth |
| Trailing P/E | 3.6xvery cheap relative to earnings |
| EPS, trailing | 2.67 |
| EPS, forward | 2.29 |
| Revenue growth | +1.6%slow but positive growth |
| Profit margin | 24.7%healthy profit margins |
| Return on equity | 34.0%an exceptional return on shareholder capital |
| FCF yield | 317.33% |
| Debt to equity | 1.88a meaningful debt load worth watching |
| Current ratio | 1.26adequate liquidity, worth monitoring |
| Beta | 1.62much more volatile than the market |
| Short interest, float | 0.13% |
| 52-week range | 9.08 - 19.95 |
| Market cap | $2.2B |
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Cayman Islands and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSTNE trades on Nasdaq (the company is based in Cayman Islands). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (16 analysts) rates it buy, with a mean price target of $18.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (16 analysts) rates it buy, with a mean price target of $18.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $10.42 | +1.7% | · | $1,017 | +1.7% |
| 2 months | $11.62 | -8.7% | $2.53 | $1,130 | +13.0% |
| 3 months | $11.43 | -7.3% | $2.53 | $1,148 | +14.8% |
| 6 months | $12.58 | -15.8% | $2.53 | $1,044 | +4.4% |
| 1 year | $11.46 | -7.5% | $2.53 | $1,146 | +14.6% |
| 2 years | $10.85 | -2.3% | $2.53 | $1,210 | +21.0% |
| 3 years | $10.49 | +1.0% | $2.53 | $1,251 | +25.1% |
| 5 years | $52.31 | -79.7% | $2.53 | $251 | -74.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever STNE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.